Market Research Logo

Conference Documentation: Controlled Release

Conference Documentation: Controlled Release

SMi is proud to announce the return of their 13th annual Controlled Release event to London in 2016! Controlled-release (CR) drug-delivery systems continue to play an important role in the treatment of diseases.

With an increase prevalence of cancer globally and advanced developments in controlled release technologies, controlled release remains the top priority for formulation scientists. Recent breakthroughs include the utilisation of nanotechnology and hydrogel polymers in controlled release mechanisms. In particular a long-acting insulin analogue shows promise for the treatment of diabetes, a unique approach which activates a micelle formation, facilitating transport of drug and significantly increasing absorption with a 10 to 50 fold increase in bioavailability.*

SMi’s 13th Controlled Release 2016 event will engage you in lively discussions with industry leaders to discover the latest innovations, as well as guiding you through the latest regulatory updates to ensure strict compliance. Through the 2-day meeting, you will learn about up and coming novel controlled release strategies to accelerate commercialisation.


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Howard Stevens, Professor, University Of Strathclyde
9:10
MHRA: Supporting innovation in controlled release and combination products
Marion Westwood, Pharmaceutical Assesor, MHRA
9:50
An industrial perspective on novel oral dose controlled release technologies
Mark Wilson, Director Platform Technology and Science , GlaxoSmithKline
10:30
Morning Coffee
11:00
Examining how Quality by Design (QbD) can aid formulation and controlled release delivery
David Elder, Externalisation Director, GlaxoSmithKline
11:40
Application of Quality-by-Design during spray drying scale-up
Sune Andersen, Principal Scientist Drying Processes, Novo Nordisk A / S
12:20
Networking Lunch
13:50
Regulatory perspective on innovative systems for controlled release
Mohammad Absar, Pharmacologist, FDA
14:30
Controlling peptide stability to unlock their therapeutic potential
Saif Shubber, Formualtion Scientist, MedImmune Inc.
15:10
Afternoon Tea
15:40
How are combination products altering the drug delivery landscape?
Howard Stevens, Professor, University Of Strathclyde
16:20
The importance of controlled release in nanomedicine design
Kathryn Hill, Associate Principal Scientist, AstraZeneca
17:00
Chairman’s Closing Remarks and Close of Day One
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
David Elder, Externalisation Director, GlaxoSmithKline
9:10
The future of controlled release peptide drug delivery
Andy Lewis, Director Novel Drug Delivery Technologies, Ipsen
9:50
Microfluidics & drug delivery systems for controlled release: production, characterisation and industrial translation
Dario Carugo, Research Fellow, University of Oxford & University of Southhampton
10:30
Morning Coffee
11:00
Dissolution testing: A key tool for a better product design
Samir Haddouchi, Managing Director, SPS Pharma Services
11:40
Parenteral controlled release: revival for increased adherence
Sachin Mittal, Senior Principal Scientist, Merck & Co Inc., Kenilworth, New Jersey, United States
12:20
Networking Lunch
13:50
How to formulate poorly soluble drugs
Rene Holm, Senior Director, H Lundbeck A/S
14:30
Multi-particulates – formulation factors and challenges during development and transfer
Inder Gulati, Formulation R&D Lead, Merck
15:10
Afternoon Tea
15:40
CriticalMix platform technology: a novel platform technology for sustained delivery of small and large API’s
Anjumn Shabir-Ahmed , Head of Pharmaceutical Science , Critical Pharmaceuticals Limited
16:20
Selection and development of controlled release technology suitable for adult and paediatric dosing
Harpreet Sandhu , Senior Director, Kashiv Pharma
17:00
Optimising drug delivery systems to mimic the human circadian rhythm
Daniel Margetson, Director CMC, Diurnal
17:40
Chairman’s Closing Remarks and Close of Day Two
David Elder, Externalisation Director, GlaxoSmithKline

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report